StocksMediumUpdated•Originally published 2 October 2026•Updated 2 October 2026•
1 min read
Integra LifeSciences Reports Preliminary Q3 Results and Updates 2026 Guidance
Key Facts
1Integra LifeSciences announced the launch of a $600 million seven-year Senior Secured Term Loan B as part of a broader refinancing transaction.
Integra LifeSciences announced preliminary unaudited financial results for the third quarter of 2026. The company stated in an official release that it has also updated its full-year 2026 financial guidance, moving to provide a revised outlook alongside its ongoing debt refinancing efforts.
The financial update follows a close for IART shares at $16.09 on October 1, 2026. These preliminary results coincide with the company's launch of a $600 million seven-year Senior Secured Term Loan B, intended to refinance existing indebtedness and support the company's financial structure under the updated guidance.